Gastric mesenchymal tumors as incidental findings during Roux-en-Y gastric bypass

• Published in: Surgery for obesity and related diseases Vol. 14; no. 1; pp. 23 - 28
• Main Authors: Cazzo, Everton, de Almeida de Saito, Helena Paes, Pareja, José Carlos, Chaim, Elinton Adami, Callejas-Neto, Francisco, de Souza Coelho-Neto, João
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-01-2018
• Subjects: Bariatric surgery; Gastric bypass; Gastrointestinal stromal tumors; Myoma; Obesity; Obesity; Gastrointestinal stromal tumors; Myoma; Bariatric surgery; Gastric bypass
• ISSN: 1550-7289; 1878-7533
• DOI: 10.1016/j.soard.2017.07.028

Occurrences of mesenchymal tumors have been more recognized in recent years, and the incidental diagnosis of these lesions during bariatric surgery has been previously reported.
To describe the cases of incidentally diagnosed mesenchymal tumors during consecutive bariatric surgeries.
Private health-providing service, Brazil.
A retrospective population-based study, which enrolled individuals who consecutively underwent Roux-en-Y gastric bypass at a single center from January 2006 through July 2016.
Of 1502 individuals, there were 16 cases (1.1%) of confirmed mesenchymal tumors. Of these 16 cases, 14 (87.5%) were gastrointestinal stromal tumors and 2 (12.5%) were leiomyomas. The affected individuals were significantly older (aged 46.2 ± 6.3 versus 35.4 ± 7.2 yr; P = .00031), presented a lower body mass index (38.2 ± 5.1 versus 45.3 ± 8.1 kg/m2; P<.00001), and had a lower weight (102.1 ± 17.9 versus 121.1 ± 7.4 kg; P = .00321). None of the individuals presented reported relapses of the mesenchymal tumors.
The possibility of incidental gastric mesenchymal tumors during bariatric surgery should not be neglected; a careful inventory of the stomach at the beginning of the procedure and resection of lesions found are mandatory. (Surg Obes Relat Dis 2017;X:XXX–XXX.) © 2017 American Society for Metabolic and Bariatric Surgery. All rights reserved.